It is composed of an inhibitor including cholesterol absorption inhibitor, a cholesterol reducing HMG-CoA inhibitor, a reducing HMG-CoA inhibitor, a rate stabilizer and a stabilizer

摘要

The drug ingredient is composed of a small amount of drug ingredient, which contains 1-20% of cholesterol absorption inhibitor of etimibe granules and simvastatian granules in weight, wherein 1-80% of ezetimibe granules and cholesterol is simvastatian by weight, and at least one preparation is 0.01-2 by weight. Copolymer stabilizers include lactose, up to 10% by weight of C acid, microcrystalline cellulose, corscarmosa sodium, povidona, BHA, ascorbic acid and citric acid. Negative, but the composition does not contain negative acid.